Datatrial to attend the Immuno Oncology One conference
7 February 2019
Datatrial are successfully involved in projects supporting three Advanced Therapy Treatment Centres (NAATTC, iMatch and NW-ATTC) established in the UK and funded by Innovate UK. These projects are to improve the data collection and reporting framework for delivering advanced therapy clinical trials.
''Our role is, through the provision of the Nucleus document platform, to provide a single source of patient and trial information for all stakeholders involved in developing and delivering advanced therapy treatments, via the use of standardised, private APIs to transport data between various third-party clinical systems.'' Jamie Pollard, Head of Software Development at Datatrial.
Advanced therapies are increasingly becoming available, and as such the skills and support framework required to administer these treatments becomes increasingly complex. Through partnership with the three ATTCs, Datatrial provide a centralised, compliant environment to collate and deliver all content related to the management and execution of advanced therapy trials.
Datatrial have considerable experience in the collection of clinical trial data via our existing EDC system, nowEDC – and with the delivery of our new management platform Nucleus we can continue to help build and support compliant data storage and clinical information sharing.
We will be attending the ImmunoOncology One Manchester Conference on Tuesday 12th February along with others from the Advanced Therapy Treatment Centre network and the Manchester based iMATCH consortium. Are you going to be there? Why not get in touch and find out more about Nucleus and our role within the ATTC’s!Back to news & blog